Bris­tol My­ers builds the case for pso­ri­a­sis hope­ful as it waits in reg­u­la­to­ry lim­bo

Bris­tol My­ers Squibb con­tin­ues to tout more da­ta for its ex­per­i­men­tal pso­ri­a­sis drug that it hopes will shake up the mar­ket.

The phar­ma­ceu­ti­cal gi­ant post­ed …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER